Compound 521
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccccc2F)c1=O
- InChi:
InChI=1S/C21H13F4N5O/c1-29-19-13(10-26-29)18-16(20(31)30(28-18)15-8-3-2-7-14(15)22)17(27-19)11-5-4-6-12(9-11)21(23,24)25/h2-10,28H,1H3
- InChiKey:
RKMNSKWAEKXLLQ-UHFFFAOYSA-N
External links
168318191 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.52 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 427.11 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 5.13 | |||
TPSA | 63.05 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4790 | Riociguat | DB08931 | |
0.4724 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4667 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4634 | Vericiguat | DB15456 | |
0.4589 | Dilmapimod | DB12140 | |
0.4582 | ATX-914 | DB12673 | |
0.4569 | Tepotinib | DB15133 | |
0.4533 | Decoglurant | DB11923 | |
0.4531 | Risdiplam | DB15305 | |
0.4516 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4507 | MK-0249 | DB11910 | |
0.4427 | Merestinib | DB12381 | |
0.4416 | Ravoxertinib | DB15281 | |
0.4328 | ABT-288 | DB15192 | |
0.4225 | EVT-101 | DB05956 |